In the initial public offering (IPO) of Techno Drugs, investors will receive 11 shares for every Tk10,000 applied, 110 shares for every Tk1 lakh applied, and 1,166 shares for up to Tk10 lakh applied.
However, non-resident Bangladeshis (NRBs) will receive slightly more shares in the company's IPO, with 20 shares allocated for every Tk10,000 applied and 2,160 shares for up to Tk10 lakh applied, according to a source at the Dhaka Stock Exchange.
Techno Drugs received applications amounting to approximately 25 times the shares allocated to general investors.
Earlier, the Bangladesh Securities and Exchange Commission granted approval to Techno Drugs for a Tk100 crore IPO under the book-building method.
The sale price of the company's shares was set at Tk34 through the book-building method, with institutional investors purchasing shares at this price. However, individual investors received a 30% discount, bringing the price to Tk24 per share.
Source : The Business Standard